Investors returned from the extended Independence Day weekend to take
profits ahead of corporate earnings season. The Dow finished the
session with a 44 points loss at 17,024 while Nasdaq fell a steeper 34
points to close at 4,451.
On the upside
of BioDelivery Sciences (Nasdaq: BDSI) surged and hit a 52-week high
after the company reported positive 2nd stage trial results for its
experimental pain drug.
Shares of Camteck (Nasdaq: CAMT) steadily rose higher today after the company announced the launch of its new Eagle product line and early orders from semiconductor device manufacturers.
Shares of Apple (Nasdaq: AAPL) bucked the trend and rose on a positive outlook based on June's sales numbers.
On the downside
of USEC (NYSE: USU) continued to give up recent gains as the uranium
fuel provider provided more details about its emergence from Chapter 11
Expedia (Nasdaq: EXPE) announced the acquisition
of Australia-based Wotif.com Holdings for approximately $650 million in
cash expanding into the Asia Pacific online travel booking market.
Advanced Technologies (Nasdaq: GTAT) was downgraded by analysts as
investors worried that the company may not be part of the expected Apple
iPhone 6 launch.
In the broad market, advancing issues were
outpaced decliners by a margin of more than 2 to 1 on the NYSE and by a
ratio of 4 to 1 on Nasdaq. The broader S&P 500 retreated from its
record high shedding 7 points to 1977. Bitcoin lost $15 to $619.